Synairgen expected to leap tomorrow on strong indications that they have progressed to Phase 3 in the US trials. They dropped to around £1.45 but £1.90 - £2 seems to be expected tomorrow, maybe much more. The informing data became available after markets closed here.
Fingers crossed.
|